Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Lung Cancer

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(1 - 20 of 37)

Pages

Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC
HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer
Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer (vol 160, pg 36, 2021)
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
A nationwide population-based cohort study of surgical care for patients with superior sulcus tumors
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
Real-world insights into patients with advanced NSCLC and MET alterations
Endobronchial ultrasound for T4 staging in patients with resectable NSCLC
Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging
Risk of second primary malignancies among patients with carcinoid of the lung
Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
The Dutch lung cancer audit

Pages